13d
First successes in the development of a gene therapy for incurable LAMA2-related muscular dystrophy
Researchers at the University of Basel have developed a gene therapy that could potentially treat a rare and currently fatal ...
TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883), a pioneering company developing innovative products for the treatment of rare genetic diseases ...
The renewal highlights ongoing progress in developing rhLAM-111 for rare muscular diseases, with a new emphasis on Duchenne Muscular Dystrophy. We are excited to have renewed our EU Orphan Drug ...
Genetic testing is available for adults as well as in vitro embryos, fetuses, newborns, and older children. Adults Adults planning to have children are advised to get genetic testing for muscular ...
The FDA gives marketing approval for a test that screens for Duchenne muscular dystrophy in newborns; acetaminophen is facing a possible statewide ban in California; the Supreme Court will not rush ...
(KXAN) — The U.S. Food and Drug Administration has authorized testing to aid in newborn screenings of Duchenne Muscular Dystrophy, a rare genetic disorder that causes progressive muscle deterioration ...
This quick alphabetical guide will help you feel more confident when talking about muscular dystrophy with your doctor and loved ones. Muscular dystrophy is the name for a group of genetic diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results